Theodore E. Hebert

Array ( [id] => 9686573 [patent_doc_number] => 20140243339 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-28 [patent_title] => 'COMBINATIONS VEGF(R) INHIBITORS AND HEPATOCYTE GROWTH FACTOR (C-MET) INHIBITORS FOR THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 14/194431 [patent_app_country] => US [patent_app_date] => 2014-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 20465 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14194431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10744269 [patent_doc_number] => 20160090420 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-31 [patent_title] => 'ANTAGONIST OF THE BTLA/HVEM INTERACTION FOR USE IN THERAPY' [patent_app_type] => utility [patent_app_number] => 14/891501 [patent_app_country] => US [patent_app_date] => 2014-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12511 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14891501 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9603032 [patent_doc_number] => 20140199714 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-17 [patent_title] => 'METHOD FOR DETECTING CANCER CELLS METASTASIZING INTO SENTINEL LYMPH NODE' [patent_app_type] => utility [patent_app_number] => 14/183050 [patent_app_country] => US [patent_app_date] => 2014-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 17834 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14183050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9901052 [patent_doc_number] => 20150056252 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-26 [patent_title] => 'Composition and Method for Diagnosis and Immunotherapy of Lung Cancer' [patent_app_type] => utility [patent_app_number] => 14/178407 [patent_app_country] => US [patent_app_date] => 2014-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10511 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14178407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10656192 [patent_doc_number] => 20160002337 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-07 [patent_title] => 'HHLA2 AS A NOVEL INHIBITOR OF HUMAN IMMUNE SYSTEM AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/770120 [patent_app_country] => US [patent_app_date] => 2014-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15557 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14770120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9510892 [patent_doc_number] => 20140147383 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-29 [patent_title] => 'DIAGNOSIS AND TREATMENT OF CANCER USING ANTI-GPR49 ANTIBODY' [patent_app_type] => utility [patent_app_number] => 14/173424 [patent_app_country] => US [patent_app_date] => 2014-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 26641 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14173424 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9510959 [patent_doc_number] => 20140147451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-29 [patent_title] => 'COMPOSITIONS COMPRISING SOLUBLE CD84 OR ANTI-CD84 ANTIBODIES AND METHODS FOR DIAGNOSING AND TREATING B-CLL' [patent_app_type] => utility [patent_app_number] => 14/172926 [patent_app_country] => US [patent_app_date] => 2014-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 20848 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14172926 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10491255 [patent_doc_number] => 20150376277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-31 [patent_title] => 'ANTI-CD83 ANTIBODIES AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/765236 [patent_app_country] => US [patent_app_date] => 2014-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 29637 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14765236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9490587 [patent_doc_number] => 20140140993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-22 [patent_title] => 'COMBINATIONS OF AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND CHEMOTHERAPEUTIC AGENTS, AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 14/166519 [patent_app_country] => US [patent_app_date] => 2014-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 28081 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14166519 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10136195 [patent_doc_number] => 09169509 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-27 [patent_title] => 'Topoisomerase 2b as a predictor of susceptibility to anthracycline-induced cardiotoxicity' [patent_app_type] => utility [patent_app_number] => 14/155858 [patent_app_country] => US [patent_app_date] => 2014-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 16734 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14155858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12036571 [patent_doc_number] => 09814784 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-11-14 [patent_title] => 'Antibody-linker-drug conjugate, preparation method therefor, and anticancer drug composition containing same' [patent_app_type] => utility [patent_app_number] => 14/655357 [patent_app_country] => US [patent_app_date] => 2014-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 29 [patent_no_of_words] => 44320 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14655357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9436072 [patent_doc_number] => 20140113979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-24 [patent_title] => 'Compositions and Methods for Detecting Cancer' [patent_app_type] => utility [patent_app_number] => 14/138879 [patent_app_country] => US [patent_app_date] => 2013-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 20501 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14138879 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12322905 [patent_doc_number] => 09943610 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-04-17 [patent_title] => Hydrophilic self-immolative linkers and conjugates thereof [patent_app_type] => utility [patent_app_number] => 14/654486 [patent_app_country] => US [patent_app_date] => 2013-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 23693 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14654486 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10275195 [patent_doc_number] => 20150160192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-11 [patent_title] => 'Antibody-Binding Protein-Drug Conjugate and Methods of Use' [patent_app_type] => utility [patent_app_number] => 14/098746 [patent_app_country] => US [patent_app_date] => 2013-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13092 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14098746 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10459567 [patent_doc_number] => 20150344583 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-03 [patent_title] => 'BCMA ANTIGEN BINDING PROTEINS' [patent_app_type] => utility [patent_app_number] => 14/649469 [patent_app_country] => US [patent_app_date] => 2013-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 54 [patent_no_of_words] => 103290 [patent_no_of_claims] => 204 [patent_no_of_ind_claims] => 120 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14649469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13287717 [patent_doc_number] => 10155031 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-12-18 [patent_title] => Individualized vaccines for cancer [patent_app_type] => utility [patent_app_number] => 14/647577 [patent_app_country] => US [patent_app_date] => 2013-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 23 [patent_no_of_words] => 45487 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 212 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14647577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9908971 [patent_doc_number] => 20150064172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-05 [patent_title] => 'METHODS OF TREATING A DISEASE OR DISORDER ASSOCIATED WITH BRUTON\'S TYROSINE KINASE' [patent_app_type] => utility [patent_app_number] => 14/084174 [patent_app_country] => US [patent_app_date] => 2013-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 36811 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14084174 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11276001 [patent_doc_number] => 09492471 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-15 [patent_title] => 'Methods of treating a disease or disorder associated with Bruton\'S Tyrosine Kinase' [patent_app_type] => utility [patent_app_number] => 14/084190 [patent_app_country] => US [patent_app_date] => 2013-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 29549 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14084190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12411993 [patent_doc_number] => 09970936 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-15 [patent_title] => Methods and materials for assessing immune system profiles [patent_app_type] => utility [patent_app_number] => 14/442465 [patent_app_country] => US [patent_app_date] => 2013-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 21 [patent_no_of_words] => 10672 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 409 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14442465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10063904 [patent_doc_number] => 09102735 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-11 [patent_title] => 'Immunoconjugates with an intracellularly-cleavable linkage' [patent_app_type] => utility [patent_app_number] => 14/048222 [patent_app_country] => US [patent_app_date] => 2013-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 27885 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14048222 [rel_patent_id] =>[rel_patent_doc_number] =>)